O Hospital Nossa Senhora da Conceição (HNSC) é um hospital público localizado em Porto Alegre, capital do estado brasileiro do Rio Grande do Sul.

During the past decade, Hospital Nossa Senhora da Conceicao conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 24 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 14 clinical trials were completed. i.e. 60.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nossa Senhora da Conceicao" #1 sponsor was "Hoffmann-La Roche" with 26 trials, followed by "Hospital Nossa Senhora da Conceicao" with 9 trials sponsored, "AIDS Clinical Trials Group" with 7 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials sponsored and "Merck Sharp & Dohme LLC" with 7 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nossa Senhora da Conceicao" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nossa Senhora da Conceicao" are "Breast Cancer" (9 trials), "HIV Infections" (7 trials), "HIV Infection" (5 trials), "Metastatic Breast Cancer" (5 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Hospital Nossa Senhora da Conceicao" in a lesser frequency.

Most popular intervention types in "Hospital Nossa Senhora da Conceicao" are "Drug" (69 trials), "Other" (14 trials), "Biological" (8 trials), "Procedure" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Atezolizumab" (13 trials), "Paclitaxel" (10 trials), "Trastuzumab" (10 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nossa Senhora da Conceicao" are 76 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Nossa Senhora da Conceicao". undefined are not yet recruiting, 11 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Hospital Nossa Senhora da Conceicao, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nossa Senhora da Conceicao, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".